Remote Neurodegeneration: Multiple Actors for One Play

Molecular Neurobiology

Volumn 50, Issue 2, 2014, Pages 368-389

  Viscomi, Maria Teresa ^a   Molinari, Marco ^a  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Apoptosis; Endocannabinoid system; Inflammation; Nitrergic system; Remote damage

Indexed keywords

CANNABINOID; CASPASE 3; ENDOCANNABINOID; GLUCOCORTICOID; HEXACHLOROBENZENE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MINOCYCLINE; NEURONAL NITRIC OXIDE SYNTHASE; PURINERGIC RECEPTOR; RAPAMYCIN; NEUROPROTECTIVE AGENT;

APOPTOSIS; ASTROCYTE; AUTOPHAGY; AXONAL INJURY; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CEREBELLECTOMY; CEREBROVASCULAR ACCIDENT; CONVALESCENCE; CYTOKINE PRODUCTION; DISEASE MODEL; ENZYME ACTIVATION; FUNCTIONAL ASSESSMENT; HUMAN; INFLAMMATION; MICROGLIA; MITOCHONDRION; MOLECULAR INTERACTION; MOLECULAR MECHANICS; MULTIPLE SCLEROSIS; NERVE CELL; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NITRERGIC NERVE; NITROSATIVE STRESS; OUTCOME ASSESSMENT; OXIDATIVE STRESS; REVIEW; SPINAL CORD INJURY; TRAUMATIC BRAIN INJURY; ANIMAL; BRAIN; DRUG EFFECTS; PATHOLOGY; SPINAL CORD INJURIES;

ANIMALS; BRAIN; HUMANS; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NEURONS; NEUROPROTECTIVE AGENTS; SPINAL CORD INJURIES;

EID: 84911002116     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-013-8629-x     Document Type: Review

References (247)

1. Bartolomeo P (2011) The quest for the ‘critical lesion site’ in cognitive deficits: problems and perspectives. Cortex 47:1010–1012
2. Zhang J, Zhang Y, Xing S, Liang Z, Zeng J (2012) Secondary neurodegeneration in remote regions after focal cerebral infarction: a new target for stroke management? Stroke 43:1700–1705
3. Carter AR, Patel KR, Astafiev SV, Snyder AZ, Rengachary J et al (2012) Upstream dysfunction of somatomotor functional connectivity after corticospinal damage in stroke. Neurorehabil Neural Repair 26:7–19
4. Viscomi MT, Florenzano F, Latini L, Molinari M (2009) Remote cell death in the cerebellar system. Cerebellum 8:184–191
5. Park E, Velumian AA, Fehlings MG (2004) The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J Neurotrauma 21:754–774
6. Block F, Dihne M, Loos M (2005) Inflammation in areas of remote changes following focal brain lesion. Prog Neurobiol 75:34–365
7. Pinching AJ, Powell TP (1971) Ultrastructural features of transneuronal cell degeneration in the olfactory system. J Cell Sci 8:253–287
8. Sakai T, Matsuda H, Watanabe N, Kamei A, Takashima S (1994) Olivocerebellar retrograde trans-synaptic degeneration from the lateral cerebellar hemisphere to the medial inferior olivary nucleus in an infant. Brain Dev 16:229–232
9. Fitzek C, Fitzek S, Stoeter P (2004) Bilateral Wallerian degeneration of the medial cerebellar peduncles after ponto-mesencephalic infarction. Eur J Radiol 49:198–203
10. Yucel Y, Gupta N (2008) Glaucoma of the brain: a disease model for the study of transsynaptic neural degeneration. Prog Brain Res 173:465–478
11. Jindahra P, Petrie A, Plant GT (2012) The time course of retrograde trans-synaptic degeneration following occipital lobe damage in humans. Brain 135:534–541
12. Yamada K, Patel U, Shrier DA, Tanaka H, Chang JK et al (1998) MR imaging of CNS tractopathy: wallerian and transneuronal degeneration. AJR Am J Roentgenol 171:813–818
13. Faden AI (2002) Neuroprotection and traumatic brain injury: theoretical option or realistic proposition. Curr Opin Neurol 15:707–712
14. Sofroniew MV, Isacson O (1988) Distribution of degeneration of cholinergic neurons in the septum following axotomy in different portions of the fimbria-fornix: a correlation between degree of cell loss and proximity of neuronal somata to the lesion. J Chem Neuroanat 1:327–337
15. Fry FJ, Cowan WM (1972) A study of retrograde cell degeneration in the lateral mammillary nucleus of the cat, with special reference to the role of axonal branching in the preservation of the cell. J Comp Neurol 144:1–23
16. Lieberman AR (1971) The axon reaction: a review of the principal features of perikaryal responses to axon injury. Int Rev Neurobiol 14:49–124
17. Hendrickson ML, Ling C, Kalil RE (2012) Degeneration of axotomized projection neurons in the rat dLGN: temporal progression of events and their mitigation by a single administration of FGF2. PLoS One 7:e46918
18. Al-Abdulla NA, Martin LJ (2002) Projection neurons and interneurons in the lateral geniculate nucleus undergo distinct forms of degeneration ranging from retrograde and transsynaptic apoptosis to transient atrophy after cortical ablation in rat. Neuroscience 115:7–14
19. Buffo A, Fronte M, Oestreicher AB, Rossi F (1998) Degenerative phenomena and reactive modifications of the adult rat inferior olivary neurons following axotomy and disconnection from their targets. Neuroscience 85:587–604
20. Buffo A, Carulli D, Rossi F, Strata P (2003) Extrinsic regulation of injury/growth-related gene expression in the inferior olive of the adult rat. Eur J Neurosci 18:2146–2158
21. Viscomi MT, Oddi S, Latini L, Bisicchia E, Maccarrone M et al (2010) The endocannabinoid system: a new entry in remote cell death mechanisms. Exp Neurol 224:56–65
22. Al-Abdulla NA, Martin LJ (1998) Apoptosis of retrogradely degenerating neurons occurs in association with the accumulation of perikaryal mitochondria and oxidative damage to the nucleus. Am J Pathol 153:447–456
23. Barron KD, Doolin PF, Oldershaw JB (1967) Ultrastructural observations on retrograde atrophy of lateral geniculate body. I. Neuronal alterations. J Neuropathol Exp Neurol 26:300–326
24. Gage FH, Wictorin K, Fischer W, Williams LR, Varon S et al (1986) Retrograde cell changes in medial septum and diagonal band following fimbria-fornix transection: quantitative temporal analysis. Neuroscience 19:241–255
25. Ruigrok TJ, de Zeeuw CI, Voogd J (1990) Hypertrophy of inferior olivary neurons: a degenerative, regenerative or plasticity phenomenon. Eur J Morphol 28:224–239
26. Viscomi MT, Florenzano F, Conversi D, Bernardi G, Molinari M (2004) Axotomy dependent purinergic and nitrergic co-expression. Neuroscience 123:393–404
27. Al-Abdulla NA, Portera-Cailliau C, Martin LJ (1998) Occipital cortex ablation in adult rat causes retrograde neuronal death in the lateral geniculate nucleus that resembles apoptosis. Neuroscience 86:191–209
28. Martin LJ, Adams NA, Pan Y, Price A, Wong M (2011) The mitochondrial permeability transition pore regulates nitric oxide-mediated apoptosis of neurons induced by target deprivation. J Neurosci 31:359–370
29. Martin LJ, Kaiser A, Yu JW, Natale JE, Al-Abdulla NA (2001) Injury-induced apoptosis of neurons in adult brain is mediated by p53-dependent and p53-independent pathways and requires Bax. J Comp Neurol 433:299–311
30. Martin LJ, Price AC, McClendon KB, Al-Abdulla NA, Subramaniam JR et al (2003) Early events of target deprivation/axotomy-induced neuronal apoptosis in vivo: oxidative stress, DNA damage, p53 phosphorylation and subcellular redistribution of death proteins. J Neurochem 85:234–247
31. Tetzlaff W, Alexander SW, Miller FD, Bisby MA (1991) Response of facial and rubrospinal neurons to axotomy: changes in mRNA expression for cytoskeletal proteins and GAP-43. J Neurosci 11:2528–2544
32. Kwon BK, Liu J, Messerer C, Kobayashi NR, McGraw J et al (2002) Survival and regeneration of rubrospinal neurons 1 year after spinal cord injury. Proc Natl Acad Sci U S A 99:3246–3251
33. Kwon BK, Liu J, Oschipok L, Teh J, Liu ZW et al (2004) Rubrospinal neurons fail to respond to brain-derived neurotrophic factor applied to the spinal cord injury site 2 months after cervical axotomy. Exp Neurol 189:45–57
34. Molinari M, Viscomi MT, Leggio MG (2013) Hemicerebellectomy. In: Manto M, Schmahmann JD, Rossi F, Gruol DL, Koibuchi N (eds) Handbook of the cerebellum and cerebellar disorders. Springer, Netherlands, pp 1579–1594
35. Castro AJ (1978) Projections of the superior cerebellar peduncle in rats and the development of new connections in response to neonatal hemicerebellectomy. J Comp Neurol 178:611–627
36. Kolodziejak A, Dziduszko J, Niechaj A, Tarnecki R (2000) Influence of acute cerebellar lesions on somatosensory evoked potentials (SEPs) in cats. J Physiol Pharmacol 51:41–55
37. Barrionuevo G, Pechadre JC, Gautron M, Guiot F (1978) Negative effects of chronic hemicerebellectomy of epileptiform after-discharges elicited by focal cortical stimulation in baboons (Papio papio). Electroencephalogr Clin Neurophysiol 44:232–235
38. Bialowas J, Hassler R, Wagner A (1984) Types of synapses and degeneration in the thalamic nucleus ventralis oralis posterior after cerebellar lesions in the squirrel monkey. J Hirnforsch 25:417–437
39. Goto N, Kaneko M (1981) Olivary enlargement: chronological and morphometric analyses. Acta Neuropathol 54:275–282
40. Birbamer G, Buchberger W, Felber S, Aichner F (1992) MR appearance of hypertrophic olivary degeneration: temporal relationships. AJNR Am J Neuroradiol 13:1501–1503
41. Uchino A, Takase Y, Nomiyama K, Egashira R, Kudo S (2006) Brainstem and cerebellar changes after cerebrovascular accidents: magnetic resonance imaging. Eur Radiol 16:592–597
42. Soblosky JS, Song JH, Dinh DH (2001) Graded unilateral cervical spinal cord injury in the rat: evaluation of forelimb recovery and histological effects. Behav Brain Res 119:1–13
43. Tohda C, Kuboyama T (2011) Current and future therapeutic strategies for functional repair of spinal cord injury. Pharmacol Ther 132:57–71
44. Wang M, Zhai P, Chen X, Schreyer DJ, Sun X et al (2011) Bioengineered scaffolds for spinal cord repair. Tissue Eng Part B Rev 17:177–194
45. Raisman G, Barnett SC, Ramon-Cueto A (2012) Repair of central nervous system lesions by transplantation of olfactory ensheathing cells. Handb Clin Neurol 109:541–549
46. Hains BC, Black JA, Waxman SG (2003) Primary cortical motor neurons undergo apoptosis after axotomizing spinal cord injury. J Comp Neurol 462:328–341
47. Nielson JL, Sears-Kraxberger I, Strong MK, Wong JK, Willenberg R et al (2010) Unexpected survival of neurons of origin of the pyramidal tract after spinal cord injury. J Neurosci 30:11516–11528
48. Nielson JL, Strong MK, Steward O (2011) A reassessment of whether cortical motor neurons die following spinal cord injury. J Comp Neurol 519:2852–2869
49. Brown LT (1974) Rubrospinal projections in the rat. J Comp Neurol 154:169–187
50. Bregman BS, Broude E, McAtee M, Kelley MS (1998) Transplants and neurotrophic factors prevent atrophy of mature CNS neurons after spinal cord injury. Exp Neurol 149:13–27
51. Feringa ER, McBride RL, Pruitt JN 2nd (1988) Loss of neurons in the red nucleus after spinal cord transection. Exp Neurol 100:112–120
52. Fukuoka T, Miki K, Yoshiya I, Noguchi K (1997) Expression of beta-calcitonin gene-related peptide in axotomized rubrospinal neurons and the effect of brain derived neurotrophic factor. Brain Res 767:250–258
53. Kobayashi NR, Fan DP, Giehl KM, Bedard AM, Wiegand SJ et al (1997) BDNF and NT-4/5 prevent atrophy of rat rubrospinal neurons after cervical axotomy, stimulate GAP-43 and Talpha1-tubulin mRNA expression, and promote axonal regeneration. J Neurosci 17:9583–9595
54. Liu PH, Wang YJ, Tseng GF (2003) Close axonal injury of rubrospinal neurons induced transient perineuronal astrocytic and microglial reaction that coincided with their massive degeneration. Exp Neurol 179:111–126
55. Mori F, Himes BT, Kowada M, Murray M, Tessler A (1997) Fetal spinal cord transplants rescue some axotomized rubrospinal neurons from retrograde cell death in adult rats. Exp Neurol 143:45–60
56. McBride RL, Feringa ER, Garver MK, Williams JK Jr (1989) Prelabeled red nucleus and sensorimotor cortex neurons of the rat survive 10 and 20 weeks after spinal cord transection. J Neuropathol Exp Neurol 48:568–576
57. Novikova LN, Novikov LN, Kellerth JO (2000) Survival effects of BDNF and NT-3 on axotomized rubrospinal neurons depend on the temporal pattern of neurotrophin administration. Eur J Neurosci 12:776–780
58. Houle JD, Ye JH (1999) Survival of chronically-injured neurons can be prolonged by treatment with neurotrophic factors. Neuroscience 94:929–936
59. Novikova LN, Novikov LN, Kellerth JO (2002) Differential effects of neurotrophins on neuronal survival and axonal regeneration after spinal cord injury in adult rats. J Comp Neurol 452:255–263
60. Zhou L, Connors T, Chen DF, Murray M, Tessler A et al (1999) Red nucleus neurons of Bcl-2 over-expressing mice are protected from cell death induced by axotomy. Neuroreport 10:3417–3421
61. Xu XM, Martin GF (1990) The response of rubrospinal neurons to axotomy in the adult opossum, Didelphis virginiana. Exp Neurol 108:46–54
62. Wannier-Morino P, Schmidlin E, Freund P, Belhaj-Saif A, Bloch J et al (2008) Fate of rubrospinal neurons after unilateral section of the cervical spinal cord in adult macaque monkeys: effects of an antibody treatment neutralizing Nogo-A. Brain Res 1217:96–109
63. Liu Y, Himes BT, Murray M, Tessler A, Fischer I (2002) Grafts of BDNF-producing fibroblasts rescue axotomized rubrospinal neurons and prevent their atrophy. Exp Neurol 178:150–164
64. Xiao M, Klueber KM, Guo Z, Lu C, Wang H et al (2007) Human adult olfactory neural progenitors promote axotomized rubrospinal tract axonal reinnervation and locomotor recovery. Neurobiol Dis 26:363–374
65. Little JW, Halar E (1985) Temporal course of motor recovery after Brown-Sequard spinal cord injuries. Paraplegia 23:39–46
66. Roth EJ, Park T, Pang T, Yarkony GM, Lee MY (1991) Traumatic cervical Brown-Sequard and Brown-Sequard-plus syndromes: the spectrum of presentations and outcomes. Paraplegia 29:582–589
67. Khaing ZZ, Geissler SA, Jiang S, Milman BD, Aguilar SV et al (2012) Assessing forelimb function after unilateral cervical spinal cord injury: novel forelimb tasks predict lesion severity and recovery. J Neurotrauma 29:488–498
68. Dihne M, Grommes C, Lutzenburg M, Witte OW, Block F (2002) Different mechanisms of secondary neuronal damage in thalamic nuclei after focal cerebral ischemia in rats. Stroke 33:3006–3011
69. Ross DT, Ebner FF (1990) Thalamic retrograde degeneration following cortical injury: an excitotoxic process? Neuroscience 35:525–550
70. Braeuninger S, Kleinschnitz C (2009) Rodent models of focal cerebral ischemia: procedural pitfalls and translational problems. Exp Transl Stroke Med 1:8
71. Agarwala S, Kalil RE (1998) Axotomy-induced neuronal death and reactive astrogliosis in the lateral geniculate nucleus following a lesion of the visual cortex in the rat. J Comp Neurol 392:252–263
72. Lieberman AR, Webster KE (1974) Proceedings: terminal and retrograde degeneration in the dorsal lateral geniculate nucleus (LGd) of the rat following cortical lesions. J Anat 118:384–386
73. Matthews MA (1973) Death of the central neuron: an electron microscopic study of thalamic retrograde degeneration following cortical ablation. J Neurocytol 2:265–288
74. Briggs F, Usrey WM (2008) Emerging views of corticothalamic function. Curr Opin Neurobiol 18:403–407
75. Florenzano F, Viscomi MT, Cavaliere F, Volonte C, Molinari M (2002) Cerebellar lesion up-regulates P2X1 and P2X2 purinergic receptors in precerebellar nuclei. Neuroscience 115:425–434
76. Barron KD (2004) The axotomy response. J Neurol Sci 220:119–121
77. Lieberman AR, Webster KE (1974) Aspects of the synaptic organization of intrinsic neurons in the dorsal lateral geniculate nucleus. An ultrastructural study of the normal and of the experimentally deafferented nucleus in the rat. J Neurocytol 3:677–710
78. Tseng GF, Wang YJ, Lai QC (1996) Perineuronal microglial reactivity following proximal and distal axotomy of rat rubrospinal neurons. Brain Res 715:32–43
79. Wang YJ, Chen JR, Tseng GF (2002) Fate of the soma and dendrites of cord-projection central neurons after proximal and distal spinal axotomy: an intracellular dye injection study. J Neurotrauma 19:1487–1502
80. Ben Taib NO, Manto M, Pandolfo M, Brotchi J (2005) Hemicerebellectomy blocks the enhancement of cortical motor output associated with repetitive somatosensory stimulation in the rat. J Physiol 567:293–300
81. Oulad Ben Taib N, Manto M (2006) Hemicerebellectomy impairs the modulation of cutaneomuscular reflexes by the motor cortex following repetitive somatosensory stimulation. Brain Res 1090:110–115
82. Ben Taib NO, Manto M (2009) Trains of transcranial direct current stimulation antagonize motor cortex hypoexcitability induced by acute hemicerebellectomy. J Neurosurg 111:796–806
83. Missitzi J, Gentner R, Geladas N, Politis P, Karandreas N et al (2011) Plasticity in human motor cortex is in part genetically determined. J Physiol 589:297–306
84. Pearson-Fuhrhop KM, Burke E, Cramer SC (2012) The influence of genetic factors on brain plasticity and recovery after neural injury. Curr Opin Neurol 25:682–688
85. Hohlfeld R, Kerschensteiner M, Meinl E (2007) Dual role of inflammation in CNS disease. Neurology 68:S58–S63, discussion S91–56
86. Esiri MM (2007) The interplay between inflammation and neurodegeneration in CNS disease. J Neuroimmunol 184:4–16
87. Stoll G, Jander S, Schroeter M (2002) Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system. Adv Exp Med Biol 513:87–113
88. Dihne M, Block F (2001) Focal ischemia induces transient expression of IL-6 in the substantia nigra pars reticulata. Brain Res 889:165–173
89. Viscomi MT, Florenzano F, Latini L, Amantea D, Bernardi G et al (2008) Methylprednisolone treatment delays remote cell death after focal brain lesion. Neuroscience 154:1267–1282
90. Kawano H, Kimura-Kuroda J, Komuta Y, Yoshioka N, Li HP et al (2012) Role of the lesion scar in the response to damage and repair of the central nervous system. Cell Tissue Res 349:169–180
91. Sofroniew MV (2009) Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 32:638–647
92. Sofroniew MV, Vinters HV (2010) Astrocytes: biology and pathology. Acta Neuropathol 119:7–35
93. Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8:57–69
94. Kim HS, Suh YH (2009) Minocycline and neurodegenerative diseases. Behav Brain Res 196:168–179
95. Lull ME, Block ML (2010) Microglial activation and chronic neurodegeneration. Neurotherapeutics 7:354–365
96. Oddi S, Latini L, Viscomi MT, Bisicchia E, Molinari M et al (2012) Distinct regulation of nNOS and iNOS by CB2 receptor in remote delayed neurodegeneration. J Mol Med (Berl) 90:371–387
97. Aloisi F (2001) Immune function of microglia. Glia 36:165–179
98. van Rossum D, Hanisch UK (2004) Microglia. Metab Brain Dis 19:393–411
99. Sofroniew MV (2005) Reactive astrocytes in neural repair and protection. Neuroscientist 11:400–407
100. Kroemer G, Galluzzi L, Brenner C (2007) Mitochondrial membrane permeabilization in cell death. Physiol Rev 87:99–163
101. Galluzzi L, Kepp O, Kroemer G (2012) Mitochondria: master regulators of danger signalling. Nat Rev Mol Cell Biol 13:780–788
102. Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281:1309–1312
103. Kroemer G, Dallaporta B, Resche-Rigon M (1998) The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 60:619–642
104. Green DR, Kroemer G (2004) The pathophysiology of mitochondrial cell death. Science 305:626–629
105. Kroemer G (1999) Mitochondrial control of apoptosis: an overview. Biochem Soc Symp 66:1–15
106. Saelens X, Festjens N, Vande Walle L, van Gurp M, van Loo G et al (2004) Toxic proteins released from mitochondria in cell death. Oncogene 23:2861–2874
107. Viscomi MT, Oddi S, Latini L, Pasquariello N, Florenzano F et al (2009) Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K/Akt pathway. J Neurosci 29:4564–4570
108. Viscomi MT, D'Amelio M, Cavallucci V, Latini L, Bisicchia E et al (2012) Stimulation of autophagy by rapamycin protects neurons from remote degeneration after acute focal brain damage. Autophagy 8:222–235
109. Klionsky DJ, Emr SD (2000) Autophagy as a regulated pathway of cellular degradation. Science 290:1717–1721
110. Levine B, Klionsky DJ (2004) Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 6:463–477
111. He C, Klionsky DJ (2009) Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 43:67–93
112. Inoue Y, Klionsky DJ (2010) Regulation of macroautophagy in Saccharomyces cerevisiae. Semin Cell Dev Biol 21:664–670
113. Mizushima N (2010) The role of the Atg1/ULK1 complex in autophagy regulation. Curr Opin Cell Biol 22:132–139
114. Xie Z, Klionsky DJ (2007) Autophagosome formation: core machinery and adaptations. Nat Cell Biol 9:1102–1109
115. Meijer AJ, Codogno P (2006) Signalling and autophagy regulation in health, aging and disease. Mol Aspects Med 27:411–425
116. Nixon RA (2006) Autophagy in neurodegenerative disease: friend, foe or turncoat? Trends Neurosci 29:528–535
117. Shintani T, Klionsky DJ (2004) Autophagy in health and disease: a double-edged sword. Science 306:990–995
118. Puyal J, Ginet V, Grishchuk Y, Truttmann AC, Clarke PG (2012) Neuronal autophagy as a mediator of life and death: contrasting roles in chronic neurodegenerative and acute neural disorders. Neuroscientist 18:224–236
119. Viscomi MT, D'Amelio M (2012) The “Janus-faced role” of autophagy in neuronal sickness: focus on neurodegeneration. Mol Neurobiol 46:513–521
120. Xing S, Zhang Y, Li J, Zhang J, Li Y et al (2012) Beclin 1 knockdown inhibits autophagic activation and prevents the secondary neurodegenerative damage in the ipsilateral thalamus following focal cerebral infarction. Autophagy 8:63–76
121. Fimia GM, Piacentini M (2010) Regulation of autophagy in mammals and its interplay with apoptosis. Cell Mol Life Sci 67:1581–1588
122. Gordy C, He YW (2012) The crosstalk between autophagy and apoptosis: where does this lead? Protein Cell 3:17–27
123. Gozuacik D, Kimchi A (2007) Autophagy and cell death. Curr Top Dev Biol 78:217–245
124. Rubinstein AD, Kimchi A (2012) Life in the balance—a mechanistic view of the crosstalk between autophagy and apoptosis. J Cell Sci 125:5259–5268
125. Federico A, Cardaioli E, Da Pozzo P, Formichi P, Gallus GN et al (2012) Mitochondria, oxidative stress and neurodegeneration. J Neurol Sci 322:254–262
126. Reynolds A, Laurie C, Mosley RL, Gendelman HE (2007) Oxidative stress and the pathogenesis of neurodegenerative disorders. Int Rev Neurobiol 82:297–325
127. Souza JM, Peluffo G, Radi R (2008) Protein tyrosine nitration—functional alteration or just a biomarker? Free Radic Biol Med 45:357–366
128. Baldwin SA, Broderick R, Osbourne D, Waeg G, Blades DA et al (1998) The presence of 4-hydroxynonenal/protein complex as an indicator of oxidative stress after experimental spinal cord contusion in a rat model. J Neurosurg 88:874–883
129. Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA et al (2007) Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 8:766–775
130. Garthwaite J, Boulton CL (1995) Nitric oxide signaling in the central nervous system. Annu Rev Physiol 57:683–706
131. Pacher P, Beckman JS, Liaudet L (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87:315–424
132. Nakamura T, Cho DH, Lipton SA (2012) Redox regulation of protein misfolding, mitochondrial dysfunction, synaptic damage, and cell death in neurodegenerative diseases. Exp Neurol 238:12–21
133. Xu M, Yip GW, Gan LT, Ng YK (2005) Distinct roles of oxidative stress and antioxidants in the nucleus dorsalis and red nucleus following spinal cord hemisection. Brain Res 1055:137–142
134. Abe N, Cavalli V (2008) Nerve injury signaling. Curr Opin Neurobiol 18:276–283
135. Rishal I, Fainzilber M (2010) Retrograde signaling in axonal regeneration. Exp Neurol 223:5–10
136. Rishal I, Fainzilber M (2013) Axon-soma communication in neuronal injury. Nat Rev Neurosci 14:278–291
137. Ibanez CF (2007) Message in a bottle: long-range retrograde signaling in the nervous system. Trends Cell Biol 17:519–528
138. Ambron RT, Walters ET (1996) Priming events and retrograde injury signals. A new perspective on the cellular and molecular biology of nerve regeneration. Mol Neurobiol 13:61–79
139. Mandolesi G, Menna E, Harauzov A, von Bartheld CS, Caleo M et al (2005) A role for retinal brain-derived neurotrophic factor in ocular dominance plasticity. Curr Biol 15:2119–2124
140. Vosler PS, Brennan CS, Chen J (2008) Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration. Mol Neurobiol 38:78–100
141. Sung YJ, Povelones M, Ambron RT (2001) RISK-1: a novel MAPK homologue in axoplasm that is activated and retrogradely transported after nerve injury. J Neurobiol 47:67–79
142. Cho Y, Sloutsky R, Naegle KM, Cavalli V (2013) Injury-Induced HDAC5 Nuclear Export Is Essential for Axon Regeneration. Cell 155:894–908
143. Bezprozvanny I (2009) Calcium signaling and neurodegenerative diseases. Trends Mol Med 15:89–100
144. Rigaud M, Gemes G, Weyker PD, Cruikshank JM, Kawano T et al (2009) Axotomy depletes intracellular calcium stores in primary sensory neurons. Anesthesiology 111:381–392
145. Perry RB, Doron-Mandel E, Iavnilovitch E, Rishal I, Dagan SY et al (2012) Subcellular knockout of importin beta1 perturbs axonal retrograde signaling. Neuron 75:294–305
146. Cavalli V, Kujala P, Klumperman J, Goldstein LS (2005) Sunday Driver links axonal transport to damage signaling. J Cell Biol 168:775–787
147. Lingor P, Koch JC, Tonges L, Bahr M (2012) Axonal degeneration as a therapeutic target in the CNS. Cell Tissue Res 349:289–311
148. Seger R, Krebs EG (1995) The MAPK signaling cascade. FASEB J 9:726–735
149. Perry RB, Fainzilber M (2009) Nuclear transport factors in neuronal function. Semin Cell Dev Biol 20:600–606
150. Burnstock G (2007) Purine and pyrimidine receptors. Cell Mol Life Sci 64:1471–1483
151. Burnstock G, Krugel U, Abbracchio MP, Illes P (2011) Purinergic signalling: from normal behaviour to pathological brain function. Prog Neurobiol 95:229–274
152. North RA, Barnard EA (1997) Nucleotide receptors. Curr Opin Neurobiol 7:346–357
153. Volonte C, Amadio S, Cavaliere F, D'Ambrosi N, Vacca F et al (2003) Extracellular ATP and neurodegeneration. Curr Drug Targets CNS Neurol Disord 2:403–412
154. Burnstock G (2008) Purinergic signalling and disorders of the central nervous system. Nat Rev Drug Discov 7:575–590
155. Burnstock G (2013) Introduction to purinergic signalling in the brain. Adv Exp Med Biol 986:1–12
156. Mayer B, Hemmens B (1997) Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem Sci 22:477–481
157. Lipton SA, Singel DJ, Stamler JS (1994) Nitric oxide in the central nervous system. Prog Brain Res 103:359–364
158. Calabrese V, Cornelius C, Rizzarelli E, Owen JB, Dinkova-Kostova AT et al (2009) Nitric oxide in cell survival: a janus molecule. Antioxid Redox Signal 11:2717–2739
159. Xu M, Ng YK, Leong SK (2000) Neuroprotective and neurodestructive functions of nitric oxide after spinal cord hemisection. Exp Neurol 161:472–480
160. Yu Y, Matsuyama Y, Nakashima S, Yanase M, Kiuchi K et al (2004) Effects of MPSS and a potent iNOS inhibitor on traumatic spinal cord injury. Neuroreport 15:2103–2107
161. Chen S, Aston-Jones G (1994) Cerebellar injury induces NADPH diaphorase in Purkinje and inferior olivary neurons in the rat. Exp Neurol 126:270–276
162. Saxon DW, Beitz AJ (1994) Cerebellar injury induces NOS in Purkinje cells and cerebellar afferent neurons. Neuroreport 5:809–812
163. Saxon DW, Beitz AJ (1996) Induction of NADPH-diaphorase/nitric oxide synthase in the brainstem trigeminal system resulting from cerebellar lesions. J Comp Neurol 371:41–71
164. Thippeswamy T, McKay JS, Quinn JP, Morris R (2006) Nitric oxide, a biological double-faced janus—is this good or bad? Histol Histopathol 21:445–458
165. Bari M, Battista N, Fezza F, Gasperi V, Maccarrone M (2006) New insights into endocannabinoid degradation and its therapeutic potential. Mini Rev Med Chem 6:257–268
166. Di Marzo V (2008) Endocannabinoids: synthesis and degradation. Rev Physiol Biochem Pharmacol 160:1–24
167. Bermudez-Silva FJ, Viveros MP, McPartland JM, Rodriguez de Fonseca F (2010) The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning? Pharmacol Biochem Behav 95:375–382
168. Di Marzo V, Matias I (2005) Endocannabinoid control of food intake and energy balance. Nat Neurosci 8:585–589
169. El Manira A, Kyriakatos A (2010) The role of endocannabinoid signaling in motor control. Physiology (Bethesda) 25:230–238
170. Pacher P, Batkai S, Kunos G (2005) Blood pressure regulation by endocannabinoids and their receptors. Neuropharmacology 48:1130–1138
171. Pacher P, Steffens S (2009) The emerging role of the endocannabinoid system in cardiovascular disease. Semin Immunopathol 31:63–77
172. Shohami E, Cohen-Yeshurun A, Magid L, Algali M, Mechoulam R (2011) Endocannabinoids and traumatic brain injury. Br J Pharmacol 163:1402–1410
173. Sanchez AJ, Garcia-Merino A (2012) Neuroprotective agents: cannabinoids. Clin Immunol 142:57–67
174. Galve-Roperh I, Aguado T, Palazuelos J, Guzman M (2008) Mechanisms of control of neuron survival by the endocannabinoid system. Curr Pharm Des 14:2279–2288
175. Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A et al (2001) An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 413:527–531
176. Garcia-Ovejero D, Arevalo-Martin A, Petrosino S, Docagne F, Hagen C et al (2009) The endocannabinoid system is modulated in response to spinal cord injury in rats. Neurobiol Dis 33:57–71
177. Fernandez-Ruiz J, Pazos MR, Garcia-Arencibia M, Sagredo O, Ramos JA (2008) Role of CB2 receptors in neuroprotective effects of cannabinoids. Mol Cell Endocrinol 286:S91–S96
178. Stella N (2010) Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas. Glia 58:1017–1030
179. Zarruk JG, Fernandez-Lopez D, Garcia-Yebenes I, Garcia-Gutierrez MS, Vivancos J et al (2012) Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection. Stroke 43:211–219
180. Pacher P, Mechoulam R (2011) Is lipid signaling through cannabinoid 2 receptors part of a protective system? Prog Lipid Res 50:193–211
181. Han S, Thatte J, Buzard DJ, Jones RM (2013) Therapeutic utility of cannabinoid receptor type 2 (CB2) selective agonists. J Med Chem 56:8224–8256
182. Fernandez-Ruiz J, Garcia C, Sagredo O, Gomez-Ruiz M, de Lago E (2010) The endocannabinoid system as a target for the treatment of neuronal damage. Expert Opin Ther Targets 14:387–404
183. Gonzalez C, Herradon E, Abalo R, Vera G, Perez-Nievas BG et al (2011) Cannabinoid/agonist WIN 55,212-2 reduces cardiac ischaemia-reperfusion injury in Zucker diabetic fatty rats: role of CB2 receptors and iNOS/eNOS. Diabetes Metab Res Rev 27:331–340
184. Maccarrone M, Fiori A, Bari M, Granata F, Gasperi V et al (2006) Regulation by cannabinoid receptors of anandamide transport across the blood-brain barrier and through other endothelial cells. Thromb Haemost 95:117–127
185. Florenzano F, Viscomi MT, Amadio S, D'Ambrosi N, Volonte C et al (2008) Do ATP and NO interact in the CNS? Prog Neurobiol 84:40–56
186. Bisicchia E, Chiurchiu V, Viscomi MT, Latini L, Fezza F et al (2013) Activation of type-2 cannabinoid receptor inhibits neuroprotective and antiinflammatory actions of glucocorticoid receptor alpha: when one is better than two. Cell Mol Life Sci 70:2191–2204
187. Kojika S, Sugita K, Inukai T, Saito M, Iijima K et al (1996) Mechanisms of glucocorticoid resistance in human leukemic cells: implication of abnormal 90 and 70 kDa heat shock proteins. Leukemia 10:994–999
188. Matysiak M, Makosa B, Walczak A, Selmaj K (2008) Patients with multiple sclerosis resisted to glucocorticoid therapy: abnormal expression of heat-shock protein 90 in glucocorticoid receptor complex. Mult Scler 14:919–926
189. Buffon F, Molko N, Herve D, Porcher R, Denghien I et al (2005) Longitudinal diffusion changes in cerebral hemispheres after MCA infarcts. J Cereb Blood Flow Metab 25:641–650
190. Herve D, Molko N, Pappata S, Buffon F, LeBihan D et al (2005) Longitudinal thalamic diffusion changes after middle cerebral artery infarcts. J Neurol Neurosurg Psychiatry 76:200–205
191. Barnes PJ (2011) Glucocorticosteroids: current and future directions. Br J Pharmacol 163:29–43
192. Chrousos GP, Kino T (2005) Intracellular glucocorticoid signaling: a formerly simple system turns stochastic. Sci STKE 2005:pe48
193. Kino T, Su YA, Chrousos GP (2009) Human glucocorticoid receptor isoform beta: recent understanding of its potential implications in physiology and pathophysiology. Cell Mol Life Sci 66:3435–3448
194. Rhen T, Cidlowski JA (2005) Antiinflammatory action of glucocorticoids—new mechanisms for old drugs. N Engl J Med 353:1711–1723
195. Sayer FT, Kronvall E, Nilsson OG (2006) Methylprednisolone treatment in acute spinal cord injury: the myth challenged through a structured analysis of published literature. Spine J 6:335–343
196. Lee HC, Cho DY, Lee WY, Chuang HC (2007) Pitfalls in treatment of acute cervical spinal cord injury using high-dose methylprednisolone: a retrospect audit of 111 patients. Surg Neurol 68(Suppl 1):S37–S41, discussion S41–32
197. Sharma A (2012) Pharmacological management of acute spinal cord injury. J Assoc Physicians India 60(Suppl):13–18
198. Mu X, Azbill RD, Springer JE (2000) Riluzole and methylprednisolone combined treatment improves functional recovery in traumatic spinal cord injury. J Neurotrauma 17:773–780
199. Weaver LC, Gris D, Saville LR, Oatway MA, Chen Y et al (2005) Methylprednisolone causes minimal improvement after spinal cord injury in rats, contrasting with benefits of an anti-integrin treatment. J Neurotrauma 22:1375–1387
200. Pereira JE, Costa LM, Cabrita AM, Couto PA, Filipe VM et al (2009) Methylprednisolone fails to improve functional and histological outcome following spinal cord injury in rats. Exp Neurol 220:71–81
201. Gomes JA, Stevens RD, Lewin JJ 3rd, Mirski MA, Bhardwaj A (2005) Glucocorticoid therapy in neurologic critical care. Crit Care Med 33:1214–1224
202. Chen X, Zhang KL, Yang SY, Dong JF, Zhang JN (2009) Glucocorticoids aggravate retrograde memory deficiency associated with traumatic brain injury in rats. J Neurotrauma 26:253–260
203. Chen X, Zhang B, Chai Y, Dong B, Lei P et al (2011) Methylprednisolone exacerbates acute critical illness-related corticosteroid insufficiency associated with traumatic brain injury in rats. Brain Res 1382:298–307
204. Bratton SL, Chestnut RM, Ghajar J, McConnell Hammond FF, Harris OA et al (2007) Guidelines for the management of severe traumatic brain injury. XV. Steroids. J Neurotrauma 24(Suppl 1):S91–S95
205. Yong VW, Wells J, Giuliani F, Casha S, Power C et al (2004) The promise of minocycline in neurology. Lancet Neurol 3:744–751
206. Tikka T, Fiebich BL, Goldsteins G, Keinanen R, Koistinaho J (2001) Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 21:2580–2588
207. Festoff BW, Ameenuddin S, Arnold PM, Wong A, Santacruz KS et al (2006) Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury. J Neurochem 97:1314–1326
208. Yune TY, Lee JY, Jung GY, Kim SJ, Jiang MH et al (2007) Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury. J Neurosci 27:7751–7761
209. Cho DC, Cheong JH, Yang MS, Hwang SJ, Kim JM et al (2011) The effect of minocycline on motor neuron recovery and neuropathic pain in a rat model of spinal cord injury. J Korean Neurosurg Soc 49:83–91
210. Wells JE, Hurlbert RJ, Fehlings MG, Yong VW (2003) Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain 126:1628–1637
211. Lam TI, Bingham D, Chang TJ, Lee CC, Shi J et al (2013) Beneficial effects of minocycline and botulinum toxin-induced constraint physical therapy following experimental traumatic brain injury. Neurorehabil Neural Repair 27:889–899
212. Homsi S, Federico F, Croci N, Palmier B, Plotkine M et al (2009) Minocycline effects on cerebral edema: relations with inflammatory and oxidative stress markers following traumatic brain injury in mice. Brain Res 1291:122–132
213. Homsi S, Piaggio T, Croci N, Noble F, Plotkine M et al (2010) Blockade of acute microglial activation by minocycline promotes neuroprotection and reduces locomotor hyperactivity after closed head injury in mice: a twelve-week follow-up study. J Neurotrauma 27:911–921
214. Stirling DP, Khodarahmi K, Liu J, McPhail LT, McBride CB et al (2004) Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J Neurosci 24:2182–2190
215. Diguet E, Fernagut PO, Wei X, Du Y, Rouland R et al (2004) Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease. Eur J Neurosci 19:3266–3276
216. Yang L, Sugama S, Chirichigno JW, Gregorio J, Lorenzl S et al (2003) Minocycline enhances MPTP toxicity to dopaminergic neurons. J Neurosci Res 74:278–285
217. Pinzon A, Marcillo A, Quintana A, Stamler S, Bunge MB et al (2008) A re-assessment of minocycline as a neuroprotective agent in a rat spinal cord contusion model. Brain Res 1243:146–151
218. Bye N, Habgood MD, Callaway JK, Malakooti N, Potter A et al (2007) Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration. Exp Neurol 204:220–233
219. Viscomi MT, Latini L, Florenzano F, Bernardi G, Molinari M (2008) Minocycline attenuates microglial activation but fails to mitigate degeneration in inferior olive and pontine nuclei after focal cerebellar lesion. Cerebellum 7:401–405
220. Chen X, Ma X, Jiang Y, Pi R, Liu Y et al (2011) The prospects of minocycline in multiple sclerosis. J Neuroimmunol 235:1–8
221. Plane JM, Shen Y, Pleasure DE, Deng W (2010) Prospects for minocycline neuroprotection. Arch Neurol 67:1442–1448
222. Xue M, Mikliaeva EI, Casha S, Zygun D, Demchuk A et al (2010) Improving outcomes of neuroprotection by minocycline: guides from cell culture and intracerebral hemorrhage in mice. Am J Pathol 176:1193–1202
223. Jung CH, Ro SH, Cao J, Otto NM, Kim DH (2010) mTOR regulation of autophagy. FEBS Lett 584:1287–1295
224. Bove J, Martinez-Vicente M, Vila M (2011) Fighting neurodegeneration with rapamycin: mechanistic insights. Nat Rev Neurosci 12:437–452
225. Chen H, Qu Y, Tang B, Xiong T, Mu D (2012) Role of mammalian target of rapamycin in hypoxic or ischemic brain injury: potential neuroprotection and limitations. Rev Neurosci 23:279–287
226. Kanno H, Ozawa H, Sekiguchi A, Itoi E (2009) The role of autophagy in spinal cord injury. Autophagy 5:390–392
227. Kanno H, Ozawa H, Sekiguchi A, Itoi E (2009) Spinal cord injury induces upregulation of Beclin 1 and promotes autophagic cell death. Neurobiol Dis 33:143–148
228. Kanno H, Ozawa H, Sekiguchi A, Yamaya S, Itoi E (2011) Induction of autophagy and autophagic cell death in damaged neural tissue after acute spinal cord injury in mice. Spine (Phila Pa 1976) 36:E1427–E1434
229. Sekiguchi A, Kanno H, Ozawa H, Yamaya S, Itoi E (2012) Rapamycin promotes autophagy and reduces neural tissue damage and locomotor impairment after spinal cord injury in mice. J Neurotrauma 29:946–956
230. Chen HC, Fong TH, Hsu PW, Chiu WT (2013) Multifaceted effects of rapamycin on functional recovery after spinal cord injury in rats through autophagy promotion, anti-inflammation, and neuroprotection. J Surg Res 179:e203–e210
231. Erlich S, Alexandrovich A, Shohami E, Pinkas-Kramarski R (2007) Rapamycin is a neuroprotective treatment for traumatic brain injury. Neurobiol Dis 26:86–93
232. Luo CL, Li BX, Li QQ, Chen XP, Sun YX et al (2011) Autophagy is involved in traumatic brain injury-induced cell death and contributes to functional outcome deficits in mice. Neuroscience 184:54–63
233. Pertwee RG (2005) Pharmacological actions of cannabinoids. Handb Exp Pharmacol 168:1–51
234. Pertwee RG (2005) The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids. AAPS J 7:E625–E654
235. van der Stelt M, Di Marzo V (2005) Cannabinoid receptors and their role in neuroprotection. Neuromolecular Med 7:37–50
236. Bahr BA, Karanian DA, Makanji SS, Makriyannis A (2006) Targeting the endocannabinoid system in treating brain disorders. Expert Opin Investig Drugs 15:351–365
237. Scotter EL, Abood ME, Glass M (2010) The endocannabinoid system as a target for the treatment of neurodegenerative disease. Br J Pharmacol 160:480–498
238. Velayudhan L, Van Diepen E, Marudkar M, Hands O, Suribhatla S et al (2013) Therapeutic potential of cannabinoids in neurodegenerative disorders: a selective review. Curr Pharm Des 33(3):755–766
239. Sagredo O, Pazos MR, Valdeolivas S, Fernandez-Ruiz J (2012) Cannabinoids: novel medicines for the treatment of Huntington's disease. Recent Pat CNS Drug Discov 7:41–48
240. Panikashvili D, Mechoulam R, Beni SM, Alexandrovich A, Shohami E (2005) CB1 cannabinoid receptors are involved in neuroprotection via NF-kappa B inhibition. J Cereb Blood Flow Metab 25:477–484
241. Panikashvili D, Shein NA, Mechoulam R, Trembovler V, Kohen R et al (2006) The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines. Neurobiol Dis 22:257–264
242. Arevalo-Martin A, Garcia-Ovejero D, Molina-Holgado E (2010) The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury. Neurobiol Dis 38:304–312
243. Amenta PS, Jallo JI, Tuma RF, Elliott MB (2012) A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury. J Neurosci Res 90:2293–2305
244. Elliott MB, Tuma RF, Amenta PS, Barbe MF, Jallo JI (2011) Acute effects of a selective cannabinoid-2 receptor agonist on neuroinflammation in a model of traumatic brain injury. J Neurotrauma 28:973–981
245. Adhikary S, Li H, Heller J, Skarica M, Zhang M et al (2011) Modulation of inflammatory responses by a cannabinoid-2-selective agonist after spinal cord injury. J Neurotrauma 28:2417–2427
246. Derkinderen P, Valjent E, Toutant M, Corvol JC, Enslen H et al (2003) Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus. J Neurosci 23:2371–2382
247. Molina-Holgado F, Pinteaux E, Heenan L, Moore JD, Rothwell NJ et al (2005) Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/AKT signaling. Mol Cell Neurosci 28:189–194